Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$12.42 - $17.29 $90,131 - $125,473
7,257 New
7,257 $113,000
Q1 2023

May 12, 2023

SELL
$56.44 - $118.81 $48,086 - $101,226
-852 Reduced 39.44%
1,308 $78,000
Q4 2022

Feb 13, 2023

BUY
$63.98 - $85.37 $138,196 - $184,399
2,160 New
2,160 $158,000
Q3 2020

Nov 12, 2020

SELL
$58.05 - $111.31 $4.24 Million - $8.14 Million
-73,100 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$57.2 - $74.41 $6.06 Million - $7.88 Million
-105,900 Reduced 59.16%
73,100 $4.34 Million
Q1 2020

May 13, 2020

BUY
$57.05 - $95.75 $10.2 Million - $17.1 Million
179,000 New
179,000 $12.1 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.49B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.